% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Heisser:166540,
author = {T. Heisser$^*$ and M. Hoffmeister$^*$ and H. Brenner$^*$},
title = {{E}ffects of {S}creening for {C}olorectal {C}ancer:
{D}evelopment, {D}ocumentation and {V}alidation of a
{M}ultistate {M}arkov {M}odel.},
journal = {International journal of cancer},
volume = {148},
number = {8},
issn = {1097-0215},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2020-02983},
pages = {1973-1981},
year = {2021},
note = {2021 Apr 15;148(8):1973-1981#EA:C070#LA:C070#},
abstract = {Simulation models are a powerful tool to overcome gaps of
evidence needed to inform medical decision making. Here, we
present development and application of a multistate Markov
model to simulate effects of colorectal cancer (CRC)
screening, along with a thorough assessment of the model's
ability to reproduce real-life outcomes. Firstly, we provide
a comprehensive documentation of the model development,
structure and assumptions. Secondly, to assess the model's
external validity, we compared model-derived cumulative
incidence and prevalences of colorectal neoplasms to (1)
results from KolosSal, a study in German screening
colonoscopy participants, (2) registry-based estimates of
CRC incidence in Germany, and (3) outcome patterns of
randomized sigmoidoscopy screening studies. We found that
(1) more than $90\%$ of observed prevalences in the KolosSal
study were within the $95\%$ confidence intervals of the
model-predicted neoplasm prevalences; (2) the 15-year
cumulative CRC incidences estimated by simulations for the
German population deviated by 0.0-0.2 percent units in men
and 0.0-0.3 percent units in women when compared to
corresponding registry-derived estimates; and (3) the time
course of cumulative CRC incidence and mortality in the
modelled intervention group and control group closely
resembles the time course reported from sigmoidoscopy
screening trials. Summarized, our model adequately predicted
colorectal neoplasm prevalences and incidences in a German
population for up to 25 years, with estimated patterns of
the effect of screening colonoscopy resembling those seen in
registry data and real-world studies. This suggests that the
model may represent a valid tool to assess the comparative
effectiveness of CRC screening strategies. This article is
protected by copyright. All rights reserved.},
keywords = {colorectal cancer (Other) / modelling (Other) / screening
(Other) / validation (Other)},
cin = {C070 / C120 / HD01},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33320964},
doi = {10.1002/ijc.33437},
url = {https://inrepo02.dkfz.de/record/166540},
}